Obesity Drug Maker Faces Investor Suit Over IPO Disclosures
By Emilie Ruscoe · January 7, 2025, 11:10 PM EST
Biopharmaceutical company BioAge Labs Inc. is facing a proposed class action alleging investors in its initial public offering were hurt by plummeting share prices after the company unexpectedly hit the brakes...
To view the full article, register now.